Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

UBS
McKinsey
Cantor Fitzgerald
Merck
McKesson
Colorcon

Generated: July 24, 2019

DrugPatentWatch Database Preview

Litigation Details for Loestrin 24 FE Antitrust Litigation (D.R.I. 2013)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Loestrin 24 FE Antitrust Litigation (D.R.I. 2013)

Docket ➤ Try a Free Trial Date Filed 2013-10-03
Court District Court, D. Rhode Island Date Terminated
Cause 28:1331 Fed. Question: Anti-trust Assigned To William E. Smith
Jury Demand Both Referred To Patricia A. Sullivan
Parties ACTAVIS, INC.; ALBERTSON'S, LLC; ALLERGAN PLC; ALLIED SERVICES DIVISION WELFARE FUND; AMERICAN SALES COMPANY, LLC; CITY OF PROVIDENCE, RHODE ISLAND; CVS PHARMACY, INC.; DENISE LOY; DIRECT PURCHASER CLASS PLAINTIFFS; ELECTRICAL WORKERS 242 & 294 HEALTH & WELFARE FUND; END PAYOR PLAINTIFFS; FRATERNAL ORDER OF POLICE, FORT LAUDERDALE LODGE 31, INSURANCE TRUST FUND; HEB GROCERY COMPANY L.P.; LABORERS' INTERNATIONAL UNION OF NORTH AMERICA LOCAL 35 HEALTH CARE FUND; LUPIN LTD.; LUPIN PHARMACEUTICALS, INC.; MARY ALEXANDER; MELISA CHRESTMAN; NEW YORK HOTEL TRADES COUNCIL & HOTEL ASSOCIATION OF NEW YORK CITY, INC. HEALTH BENEFITS FUND; PAINTERS DISTRICT COUNCIL NO. 30 HEALTH & WELFARE FUND; PLAINTIFFS; RITE-AID CORPORATION; RITE-AID HDQTRS. CORP.; ROCHESTER DRUG CO-OPERATIVE, INC.; SAFEWAY, INC.; TEAMSTERS LOCAL 237 WELFARE BENEFITS FUND; THE KROGER CO.; UNITED FOOD AND COMMERCIAL WORKERS LOCAL 1776 & PARTICIPATING EMPLOYERS HEALTH AND WELFARE FUND; WALGREEN CO.; WARNER CHILCOTT (US), LLC; WARNER CHILCOTT COMPANY, INC.; WARNER CHILCOTT COMPANY, LLC; WARNER CHILCOTT CORPORATION; WARNER CHILCOTT HOLDINGS COMPANY III, LTD.; WARNER CHILCOTT LABORATORIES IRELAND LIMITED; WARNER CHILCOTT PUBLIC LIMITED COMPANY; WARNER CHILCOTT SALES (US), LLC; WATSON LABORATORIES, INC.; WATSON PHARMACEUTICALS, INC.
Patents 4,826,831; 5,108,995; 5,552,394
Attorneys Alison Hanstead; Angela D. Daker; Anna T. Neill; April D. Lambert; Barry L. Refsin; Christian Richard Jenner; Christopher W. Cantrell; Daniel J. Walker; Daniel P. Thiel; Danielle M. Audette; Donald A. Migliori; Donna M Evans; Elizabeth G. Arthur; Eric L. Bloom; Holly Smith Letourneau; J. Mark Gidley; Jack E. Pace , III; James R. Dugan , II; James R. Hail; Jeffrey B. Pine; Jeffrey M. Padwa; John A. Tarantino; John Douglas Richards; John Radice; Katherine Dyson; Katie Glynn; Kiersten A. Taylor; Kristen Johnson Parker; Lauren C. Ravkind; Lauren Papenhausen; Leiv Blad; Maria F. Deaton; Marvin A. Miller; Matthew C. Weiner; Matthew T. Jerzyk; Megan K Maciasz DiSanto; Michael M. Buchman; Michelle C. Zolnoski; Monica L. Rebuck; Neill W. Clark; Nicole J. Benjamin; Patricia K. Rocha; Paul J. Skiermont; Paul M. Eckles; Paul M. Kessimian; Robert A. Milne; S. Michael Levin; Santiago H. Posas; Sarah E. Spires; Sarah Spires; Scott E. Perwin; Sean M. Tepe; Steven C. Sunshine; Thomas M. Sobol; William J. Doyle , II; William R. Landry; ZACHARY D. CAPLAN; Zarema A. Jaramillo
Firms Assistant City Solicitor, Law Department; Berger & Montague PC; Berger & Montague, P.C.; Blish & Cavanagh; Cohen Milstein Sellers & Toll PLLC; Doyle Lowther LLP; Faruqi and Faruqi LLP; Hagens Berman Sobol Shapiro LLP; Hangley Aronchick Segal Pudlin and Schiller; Hilliard & Shadowen LLC; Hilliard & Shadowen LLP; Lowenstein Sandler LLP; Lowenstein Sandler, LLP; Lynch & Pine, LLC; Morgan Lewis and Bockius LLP; Motley Rice LLC; Oliverio & Marcaccio LLP; Radice Law Firm PC; S. Michael Levin; Senior Assistant City Solicitor, Providence Solicitor's Office; Skadden, Arps, Slate, Meager & Flom; Skadden, Arps, Slate, Meager & Flom LLP; Skiermont Derby LLP; The Law Offices of Matthew Jerzyk LLC; White & Case; White & Case LLP; White and Case
Link to Docket External link to docket
Small Molecule Drugs cited in Loestrin 24 FE Antitrust Litigation

Details for Loestrin 24 FE Antitrust Litigation (D.R.I. 2013)

Date Filed Document No. Description Snippet Link To Document
2014-09-04 116 16.) The resulting patent, U.S. Patent No. 5,552,394 (the “’394 Patent”), is titled “Low…any relevant patents; (2) any relevant patents have expired; or (3) a relevant patent is soon to expire…settlement payments in patent infringement suits made by a patent holder to an alleged infringer…challenges the patents on a major drug”). C. Loestrin 24 and the ‘394 Patent The active… validity of the patent; and parties may well find ways to settle patent disputes without the External link to document
2016-02-24 149 Nevertheless, U.S. Patent No. 5,552,394 (the "'394 Patent"), entitled …must include "the patent number and the expiration date of any patent which claims the drug…listed any relevant patents. It can certify that any relevant patents have expired. It… patents expire. Or, it can certify that any listed, relevant patent "is …infringer, not to produce the patented product until the patent's term expires, and (2 External link to document
2016-05-09 164 U.S. Patent No. 5,552,394 (the “’394 patent”). Warner Chilcott later acquired the ’394 patent. On February…. Patents are not bulletproof. 46. Patents are not bulletproof. Patents are routinely…information while prosecuting the patent. 4. First, the patent application cited only favorable…acquisition of Hodgen’s patent application. 5. Second, when the patent examiner focused on …merits – the stark light of patent litigation would reveal that the ’394 patent was invalid and unenforceable External link to document
2017-08-08 307 /17686 publication, U.S. Patent No. 5,108,995, and U.S. Patent No. 4,826,831).) They also allege…assignee of the patent covering Loestrin 24, U.S. Patent No. 5,552,394 (“the ‘394 patent”), and it holds… any relevant patents; (2) any relevant patents have expired; or (3) a relevant patent is soon to expire…material to the patentability of the claims of the ‘394 Patent because the claims of the patent extend the…payments” – settlement payments in patent infringement suits remitted by patent holders to alleged infringers External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
McKesson
Healthtrust
Federal Trade Commission
Queensland Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.